What is the primary driver of revenue growth for UnitedHealth Group in this period?

UnitedHealth Group's revenue growth is driven by a combination of factors, including acquisitions (such as Amil), organic growth in its UnitedHealthcare and Optum businesses, and an increase in the number of individuals served by its benefit products. Specifically, the Optum segment saw substantial revenue growth due to expansion in OptumHealth, OptumInsight, and OptumRx, notably with the insourcing of pharmacy benefit programs.

What challenges is the UnitedHealthcare segment facing?

The UnitedHealthcare segment is experiencing pressure from several factors, including reductions in Medicare Advantage rates, which are impacting revenues. Additionally, there has been a decrease in favorable medical cost development, and changes in business mix, with a greater proportion of business in government programs, have also affected profitability. The conversion of a large commercial customer from a risk-based to a fee-based arrangement also reduced reported revenues, although with a negligible impact on earnings.

How is the company managing its capital and returning value to shareholders?

UnitedHealth Group is actively managing its capital by continuing its share repurchase program, having repurchased $2.3 billion worth of shares in the first nine months of 2013, and by increasing its quarterly dividend to an annualized rate of $1.12 per share. The company also maintains robust liquidity with substantial cash and investment balances, and has access to credit facilities, indicating a strong financial position to support these capital return initiatives.

What is the significance of the Optum segment's performance?

The Optum segment is a key growth engine for UnitedHealth Group, demonstrating robust revenue growth (33% for the nine months) and significant increases in earnings from operations (69% for the nine months). Its diversified services in health, technology, and pharmacy solutions are contributing substantially to the company's overall financial performance and strategic objectives, offering insights into the future direction of healthcare services.

UNH 10-Q Quarterly Report Q3 FY2013 — Revenue, Net Income, EPS

Summary

UnitedHealth Group's third quarter 2013 filing shows continued revenue growth, driven by both its UnitedHealthcare and Optum platforms. Total revenues increased by 12% year-over-year for both the three and nine months ended September 30, 2013, propelled by acquisitions and organic growth. However, earnings from operations saw a slight decline of 1% for the nine-month period, primarily due to decreased earnings in the UnitedHealthcare segment, which faced pressures from Medicare Advantage rate reductions and less favorable medical cost development. The Optum segment continues to be a strong growth driver, with revenues up 33% and earnings from operations increasing by 54% for the quarter. This growth is attributed to expansion across OptumHealth, OptumInsight, and OptumRx, including the significant insourcing of pharmacy benefit programs. The company also highlighted its commitment to shareholder returns, increasing its quarterly dividend and continuing its share repurchase program, demonstrating confidence in its financial position and future prospects despite ongoing regulatory and market challenges in the healthcare industry.

Financial Highlights

55 data points

Beta

Revenue

$30.62B

1.0% Gross Margin

Net Income

$1.57B

0.1% Net Margin

EPS (Diluted)

$1.53

Total Assets

$81.86B

Cash & Equivalents

$8.29B

Free Cash Flow

$3.04B

Financial Statements

Beta

Revenue	$30.62B
Cost of Revenue	$731.00M
Gross Profit	$29.89B
SG&A Expenses	$4.87B
Operating Expenses	$27.99B
Operating Income	$2.63B
Interest Expense	$178.00M
Net Income	$1.57B
EPS (Basic)	$1.56
EPS (Diluted)	$1.53
Shares Outstanding (Basic)	1.00B
Shares Outstanding (Diluted)	1.02B

Key Highlights

1Consolidated revenues grew 12% year-over-year for the nine months ended September 30, 2013, reaching $91.4 billion, driven by acquisitions and organic growth across both UnitedHealthcare and Optum segments.
2Optum segment revenue surged by 33% to $26.8 billion for the nine-month period, with strong contributions from OptumHealth, OptumInsight, and OptumRx, showcasing its increasing importance to the company's overall performance.
3UnitedHealthcare's earnings from operations decreased by 11% year-over-year to $5.5 billion for the nine months, impacted by Medicare Advantage rate reductions and a decrease in favorable medical cost development.
4UnitedHealthcare experienced significant membership growth, serving 45.3 million medical members as of September 30, 2013, an increase of 8.7 million from the prior year, bolstered by international expansion and TRICARE contracts.
5The company returned capital to shareholders through share repurchases totaling $2.3 billion for the nine months and increased its quarterly dividend to an annualized rate of $1.12 per share.
6Despite a slight year-over-year decrease in net earnings attributable to common shareholders for the nine-month period ($4.2 billion vs. $4.3 billion), diluted earnings per share remained stable at $4.09.
7The company maintained a strong liquidity position with $8.3 billion in cash and cash equivalents and $19.5 billion in debt securities as of September 30, 2013, supporting ongoing operations and strategic initiatives.

UNITEDHEALTH GROUP INC Quarterly Report for Q3 Ended Sep 30, 2013

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions